ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,228Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 1121

$1.07M Total Retail Price of All Prescriptions

Rank: 57 out of 1121

749 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 749 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 14,223 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
AMLODIPINE BESYLATE 1,595 1,183 1 5
SIMVASTATIN 924 687 2 1
METFORMIN HCL 662 496 3 8
FUROSEMIDE 642 494 4 7
LISINOPRIL 552 380 5 4
CARVEDILOL 424 286 6 20
AMLODIPINE BESYLATE-BENAZEPRIL 410 320 7 65
METOPROLOL TARTRATE 368 280 8 9
TRIAMTERENE-HCTZ 345 223 9 38
BENAZEPRIL HCL 336 238 10 41
MELOXICAM 318 205 11 22
OMEPRAZOLE 315 198 12 6
GLIMEPIRIDE 314 263 13 34
POTASSIUM CHLORIDE 302 241 14 12
LOSARTAN POTASSIUM 297 228 15 17
DIOVAN 264 183 16 45
RANITIDINE HCL 254 156 17 33
CLONIDINE HCL 254 186 17 39
METFORMIN HCL ER 238 141 19 47
HYDROCHLOROTHIAZIDE 235 196 20 10
INSULIN SYRINGE 220 120 21 77
GABAPENTIN 210 129 22 13
LANTUS 206 134 23 52
LOVASTATIN 206 138 23 26
ATENOLOL 180 160 25 16
TAMSULOSIN HCL 178 147 26 32
LEVOTHYROXINE SODIUM 176 125 27 2
ALLOPURINOL 175 151 28 30
PLAVIX 174 142 29 42
KLOR-CON 10 166 108 30 69
CLOPIDOGREL 162 126 31 27
WARFARIN SODIUM 161 92 32 11
GLIPIZIDE 156 122 33 84
EXFORGE 156 140 33 190
FLUCONAZOLE 148 78 35 156
METOPROLOL SUCCINATE 148 108 35 23
GLYBURIDE 147 102 R 37 51
PROAIR HFA 145 71 38 48
SPIRONOLACTONE 141 120 39 54
CRESTOR 140 90 40 28
ATORVASTATIN CALCIUM 140 91 40 15
ACYCLOVIR 137 38 42 306
DIGOXIN 136 96 43 59
SPIRIVA 133 59 44 49
NEXIUM 132 109 45 24
HYDRALAZINE HCL 126 82 46 66
TRIAMTERENE-HYDROCHLOROTHIAZID 126 103 46 154
SINGULAIR 114 100 48 78
BYSTOLIC 113 93 49 121
ISOSORBIDE MONONITRATE ER 109 87 50 62
PRAVASTATIN SODIUM 105 100 51 14
DONEPEZIL HCL 104 94 52 35
GLIPIZIDE ER 103 99 53 142
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 78 54 31
WELCHOL 99 48 55 208
JANUVIA 97 54 56 81
CIPROFLOXACIN HCL 92 68 57 57
COMBIVENT 87 39 58 129
COREG CR 85 73 59 375
VENTOLIN HFA 83 36 60 92
LOVAZA 79 41 61 210
NOVOLOG MIX 70-30 77 53 62 232
NIASPAN 76 63 63 166
QUINAPRIL HCL 74 69 64 127
TRIAMCINOLONE ACETONIDE 67 46 65 169
AMITRIPTYLINE HCL 66 39 R 66 61
SINGLE USE SWAB 66 30 66 302
MONTELUKAST SODIUM 65 38 68 144
FAMOTIDINE 65 38 68 63
AGGRENOX 65 48 68 177
TERAZOSIN HCL 65 63 68 130
NAPROXEN 64 41 72 116
PHENYTOIN SODIUM EXTENDED 64 34 72 135
BENICAR 60 50 74 176
ALENDRONATE SODIUM 60 55 74 37
DILTIAZEM ER 59 33 76 105
LIPITOR 58 53 77 106
KLOR-CON M20 57 51 78 85
PANTOPRAZOLE SODIUM 56 43 79 29
TRAMADOL HCL 56 42 79 25
VERAPAMIL ER 56 31 79 89
SERTRALINE HCL 55 39 82 21
NOVOLOG 55 28 82 139
HYDROCODONE-ACETAMINOPHEN 54 34 S3 84 3
CITALOPRAM HBR 53 14 85 18
AMOXICILLIN 53 33 85 140
ZOSTAVAX 52 44 87 268
LOSARTAN-HYDROCHLOROTHIAZIDE 52 33 87 46
NYSTATIN 51 23 89 147
CARTIA XT 51 50 89 267
HUMALOG 50 25 91 150
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.